Mylan finalises $465m settlement with US government

18-08-2017

Mylan has finalised a $465 million payment to the US government to settle a lawsuit about the classification of EpiPen Auto-Injector (epinephrine) under the Medicaid Drug Rebate Program.


Mylan, EpiPen, US Department of Justice, CMS, rebate, generics, False Claims Act, Medicaid

More on this story

Mylan to pay US government $465m over EpiPen
11-10-2016

LSIPR